Wednesday, February 10, 2010, 1:36am EST - Canadian Markets open in 7 hours and 54 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

World Heart Corp. (WHRT)

 On Feb 9: 5.80 USD  Down 0.34 (5.54%)  
MORE ON WHRT
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
World Heart Corporation (NCM:WHRT) Delayed quote dataEdit
Last Trade: 5.80 USD
Trade Time: Feb 9
Change: Down 0.34 (5.54%)
Prev Close: 6.14
Open: 6.05
Bid: 4.39 x 600
Ask: N/A
1y Target Est: 7.50
Day's Range: 5.56 - 6.15
52wk Range: 1.70 - 8.63
Volume: 10,344
Avg Vol (3m): 3,623.81
Market Cap: 77.21M
P/E (ttm): N/A
EPS (ttm): -1.18
Div & Yield: N/A (N/A%)
World Heart Corp. (WHRT)
1d  5d  3m  6m  1y  2y  5y  max 
 Add WHRT to Portfolio   Download Data

HEADLINES
• WORLD HEART CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;
EDGAR Online (Fri, Feb 5)
• World Heart Corporation Announces the Election of a New Director
CNW Group (Fri, Feb 5)
• World Heart Corporation Announces the Election of a New Director
PRNewswire (Fri, Feb 5)
• NASDAQ Stock Market Confirms WorldHeart's Compliance With NASDAQ Listing Rule 5605
CNW Group (Fri, Feb 5)
• NASDAQ Stock Market Confirms WorldHeart's Compliance With NASDAQ Listing Rule 5605
PRNewswire (Fri, Feb 5)
• WorldHeart Participates in NIH Award for Further Development of a Miniaturized MagLev VAD
CNW Group (Thu, Feb 4)
• WorldHeart Participates in NIH Award for Further Development of a Miniaturized MagLev VAD
PRNewswire (Thu, Feb 4)
• WORLD HEART CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Feb 4)
• Coverage initiated on World Heart by Wedbush Morgan
Briefing.com (Tue, Feb 2)
• WORLD HEART CORP Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and Exhibits
EDGAR Online (Wed, Jan 27)
More Headlines for WHRT...
ANALYST
EPS Est (next year) (Dec-98) : N/A
EPS Est (in 2 years) (Dec-99) : N/A
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
World Heart Corporation, together with its subsidiaries, primarily focuses on the manufacture, development, commercialization, and distribution of implantable ventricular assist devices (VADs).

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices